+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia

Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia

Leukemia and Lymphoma 25(3-4): 301-311

Whole-blood three-color immunofluorescence analysis was used to investigate the role of CD5/CD72 and CD21/CD23 receptor-ligand pair formation on B-chronic lymphocytic leukemia (B-CLL) cells as well as sCD23 and bcl-2 oncoprotein expression in disease progression and activity and total tumor mass in B-cell chronic leukemia (B-CLL) patients. Thirty-four patients with B-CLL and 19 controls were included in the study. The majority of B-cells in B-CLL patients coexpressed CD5 and CD72 as well as the CD23 antigen. Unlike B-cells in B-CLL patients, B-cells in all healthy controls tested had high expression of CD21 antigen. We identified two groups of B-CLL patients according to high (n = 20) or low levels (n = 14) of CD21 expression on CD19+CD23+ B-cells. Only in the patients with high CD21 expression, were sCD23 levels positively correlated with factors known to have prognostic significance in B-CLL (Rai stage and TTM) and could, therefore, be used as a prognostic parameter for these B-CLL patients. Bcl-2 oncoprotein expression did not differ between these patient groups. We presumed that in patients with a lower expression of CD21 antigen, the contribution of the CD21 molecule to homotypic adhesion was lacking. Further studies are necessary to determine the possible association of higher expression of the CD21 antigen with disease progression and the aggressive character of the B-CLL.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 046973811

Download citation: RISBibTeXText

PMID: 9168440

DOI: 10.3109/10428199709114169

Related references

Comprehensive analysis of BAFF binding receptor profiles and receptor occupancy in B cell chronic lymphocytic leukemia: Identification of discrete phenotypic subgroups.. 2007

Phenotypic heterogeneity of B cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. American Journal of Clinical Pathology 119(6): 824-832, 2003

Analysis of TNF-receptor and ligand superfamily molecules involved in B-cell chronic lymphocytic leukemia apoptotic programs following CD40-CD40L interaction. Blood 96(11 Part 1): 749a, 2000

Hairy cell leukemia hcl like phenotypic expression on chronic lymphocytic leukemia cll cells. Proceedings of the American Association for Cancer Research Annual Meeting 31: 262, 1990

CD40 ligand rescues chronic lymphocytic leukemia cells from spontaneous apoptosis and mediates resistance to FAS ligand and fludarabine. Blood 88(10 Suppl. 1 Part 1-2): 236A, 1996

Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming. Oncotarget 7(26): 40558-40570, 2016

Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses. Leukemia and Lymphoma 52(7): 1290-1301, 2011

The cytochemistry of b chronic lymphocytic leukemia cells correlation of acid hydrolases expression with the maturation stage of b chronic lymphocytic leukemia cells stimulated by 12 o tetradecanoylphorbol 13 acetate. Quaglino, D And F G J Hayhoe (Ed ) Serono Symposia Publications From Raven Press, Vol 20 The Cytobiology Of Leukaemias And Lymphomas Xxi+501p Raven Press: New York, N Y , Usa Illus 245-248, 1985

Functional and phenotypic properties of in vitro differentiating chronic lymphocytic leukemia cells. Journal of Cellular Biochemistry Suppl. (6): 21, 1982

Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood 110(9): 3316-3325, 2007

Cytoplasmic and surface membrane phenotypic markers in cells of B cell chronic lymphocytic leukemia. Neoplasma 41(2): 69-74, 1994

Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood 85(12): 3556-3565, 1995

Generation of non mhc restricted killing in cultures stimulated with b cells from chronic lymphocytic leukemia patients phenotypic characterization of the precursor and effector cells. Clinical & Experimental Immunology 72(2): 303-308, 1988

CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells. Journal of Immunology 177(10): 6713-6722, 2006

High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. American Journal of Clinical Pathology 132(4): 589-596, 2009